Antifungal News and Research

RSS

UC Davis researchers call for global action on antifungal resistance

UC Davis infectious diseases experts George Thompson and Angel Desai are raising the alarm about the role new pesticides can play in building resistance to antifungal medical treatments.

9 Jun 2025

Climate models predict spread of deadly Aspergillus pathogens

Climate change is projected to shift the global distribution of key Aspergillus species, with northward movement of suitable habitats and changing risks for human health and agriculture. Advanced modelling reveals significant implications for food security and clinical fungal infections.

26 May 2025

Magnolia essential oil fights bacteria and oxidative stress with natural potency

...

17 Apr 2025

Singapore launches a strategic new standard to strengthen disinfectant market

As public awareness of hygiene and infection control grows in a post-pandemic world, Singapore has launched a strategic national standard to strengthen public health and industry accountability in the rapidly expanding disinfectant market.

4 Apr 2025

WHO releases first reports on shortages in fungal disease treatments and diagnostics

The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps.

2 Apr 2025

New monoclonal antibody shows promise in treating mucormycosis

Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of natural disasters.

22 Mar 2025

Advances in the design and synthesis of isosteviol derivatives

Announcing a new publication for Acta Materia Medica journal. Isosteviol and its derivatives, diterpene compounds with a wide range of biological activities, play important antiviral, antibacterial, antioxidant, antitumor, analgesic, anti-inflammatory, antipyretic, antifungal, and anticardiovascular disease roles.

11 Feb 2025

Understanding infection risks in pediatric hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

7 Feb 2025

Carrots may offer natural support for people with type 2 diabetes

Could an ordinary carrot improve the treatment of type 2 diabetes? A new study from SDU suggests so.

8 Jan 2025

University of Exeter launches new round of funding for fungal AMR solutions

A University of Exeter funding scheme designed to combat the global challenge of fungal antimicrobial resistance (fAMR) has announced a new call for applications.

8 Jan 2025

Solving a decades-long puzzle in leishmaniasis drug development

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that afflicts about 1 million people and kills about 30,000 people around the world every year.

20 Dec 2024

Key risk factors influencing mortality rates in chronic pulmonary aspergillosis patients

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, highlighting the need for targeted therapies.

3 Dec 2024

Fungus found in the mouse stomach may hold a key to fungal evolution in the gut

A fungus discovered in the mouse stomach may hold a key to fungal evolution within the gastrointestinal tract, according to new research led by Weill Cornell Medicine investigators.

27 Nov 2024

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Antibiotic exposure shows potential protective effects against Parkinson's, while antifungal use is linked to increased risk, indicating microbiome involvement.

28 Oct 2024

MALDI-TOF mass spectrometry proves effective for diagnosing onychomycosis in nail psoriasis

Nail psoriasis is common in patients with plaque psoriasis and is associated with morbidity, including onychomycosis, which can complicate psoriasis treatments and be difficult to differentiate.

26 Oct 2024

Multiple courses of penicillin antibiotics linked to lower risk of Parkinson's disease

A Rutgers Health study has found that people who took multiple courses of penicillin antibiotics had a modestly lower risk of developing Parkinson's disease, a surprising finding that researchers say highlights the complex relationship between bacteria in the digestive tract and brain health.

23 Oct 2024

Discovery of new bacterial toxins opens path to novel infection treatments

Researchers have discovered a new group of bacterial toxins that can kill harmful bacteria and fungi, opening the door to potential new treatments for infections.

22 Oct 2024

Policy change linked to rise in treatment-resistant vaginal thrush

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, suggests the first study of its kind, published online in the journal Sexually Transmitted Infections.

8 Oct 2024

Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients

Study reveals 0.4%-2.7% incidence of COVID-19-associated pulmonary aspergillosis in severe patients, highlighting significant mortality risks and risk factors.

24 Sep 2024

Researchers analyze incidence of COVID-19-associated pulmonary aspergillosis in Japan

As society learns to live with COVID-19, research on the disease and its complications remains important.

20 Sep 2024